REQUEST A DEMO
Total
USD $0.00
Search more companies

Bio Medical Pharma Sp. z o.o. (Poland)

Main Activities: Electronic Shopping and Mail-Order Houses
Secondary Activities: All Other Miscellaneous Food Manufacturing | Pharmaceutical Preparation Manufacturing | Toilet Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | All Other Professional, Scientific, and Technical Services | Packaging and Labeling Services | Other Personal and Household Goods Repair and Maintenance
Full name: Bio Medical Pharma Sp. z o.o. Profile Updated: December 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Bio Medical Pharma is a company that specializes in dietary supplements, including the Licur 7000 with vitamin D, which is known for its increased biodisponibility.

Headquarters
Ul. Kaczencowa 10F
Lodz; Lodzkie; Postal Code: 91-214

Contact Details: Purchase the Bio Medical Pharma Sp. z o.o. report to view the information.

Website: http://www.bmpharma.pl/

Basic Information
Total Employees:
Purchase the Bio Medical Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Bio Medical Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Bio Medical Pharma Sp. z o.o. report to view the information.
Incorporation Date:
January 02, 2014
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Bio Medical Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-35.1%
Total operating revenue
-35.26%
Operating profit (EBIT)
-94.02%
EBITDA
-93.26%
Net Profit (Loss) for the Period
-94.03%
Total assets
-9.61%
Total equity
0.85%
Operating Profit Margin (ROS)
-10.48%
Net Profit Margin
-8.48%
Return on Equity (ROE)
-13.39%
Quick Ratio
1.21%
Cash Ratio
0.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?